High pathologic complete response after primary chemotherapy in patients treated with weekly paclitaxel followed by FEC chemotherapy with simultaneous trastuzumab in Her-2 positive operable breast cancer

被引：0
|
作者：
Pernas, S.
Gil Gil, M.
Urruticoechea, A.
Fernandez-Ortega, A.
Falo, C.
Piulats, J. M.
Prieto, L.
Pla, M. J.
Moreno, A.
Germa, J. R.
机构：
[1] Hosp Barcelona, Inst Catala Oncol DIR, Barcelona, Spain
[2] Hosp Barcelona, HU Bellvitge, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [41] Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab
    Fujita, Noriko
    Enomoto, Yukie
    Inakami, Keiko
    Yanagisawa, Tetsu
    Iguchi, Chikage
    Aono, Toyokazu
    Nomura, Takashi
    Yamamoto, Hitoshi
    Kasugai, Tsutomu
    Shiba, Eiichi
    [J]. ONCOLOGY, 2020, 98 (01) : 35 - 41
  • [42] Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience
    Singh, Jasmeet C.
    Mamtani, Anita
    Barrio, Andrea
    Morrow, Monica
    Sugarman, Steven
    Jones, Lee W.
    Yu, Anthony F.
    Argolo, Daniel
    Smyth, Lilian M.
    Modi, Shanu
    Schweber, Sarah
    Boafo, Camilla
    Patil, Sujata
    Norton, Larry
    Baselga, Jose
    Hudis, Clifford A.
    Dang, Chau
    [J]. ONCOLOGIST, 2017, 22 (02): : 139 - 143
  • [43] High pathologic complete response (pCR) in HER2-positive breast cancer to novel nonanthracycline neoadjuvant chemotherapy.
    Zelnak, A. B.
    Leyland-Jones, B.
    Gabram-Mendola, S.
    Styblo, T. M.
    Rizzo, M.
    Wood, W. C.
    Srinivasiah, J.
    Jonas, W. S.
    Schnell, F. M.
    O'Regan, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Pathologic Complete Response in HER2-Positive Breast Cancer Patients Receiving Trastuzumab in Neoadjuvant Setting
    Sheikh, Fareeha
    Nazir, Adil
    Yasmeen, Samia
    Badar, Farhana
    Ahmad, Usman
    Siddiqui, Neelam
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (02): : 159 - 163
  • [45] Remarkable complete pathologic response rate after preoperative paclitaxel, gemcitabine, and trastuzumab chemotherapy in HER2 positive stage III/III breast cancer: a phase II multicenter study.
    Im, S-A
    Lee, K. S.
    Lee, E. S.
    Kwon, Y.
    Noh, D-Y
    Park, I-A
    Ahn, J-H
    Ahn, J. S.
    Kim, J. H.
    Nam, B-H
    Ro, J.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 331S - 332S
  • [46] Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
    Sagar Sardesai
    Jasmine Sukumar
    Mahmoud Kassem
    Marilly Palettas
    Julie Stephens
    Evan Morgan
    Daniel Addison
    Ragavendra Baliga
    Daniel G. Stover
    Jeffrey VanDeusen
    Nicole Williams
    Mathew Cherian
    Maryam Lustberg
    Robert Wesolowski
    Bhuvaneswari Ramaswamy
    [J]. Cardio-Oncology, 6
  • [47] Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
    Sardesai, Sagar
    Sukumar, Jasmine
    Kassem, Mahmoud
    Palettas, Marilly
    Stephens, Julie
    Morgan, Evan
    Addison, Daniel
    Baliga, Ragavendra
    Stover, Daniel G.
    VanDeusen, Jeffrey
    Williams, Nicole
    Cherian, Mathew
    Lustberg, Maryam
    Wesolowski, Robert
    Ramaswamy, Bhuvaneswari
    [J]. CARDIO-ONCOLOGY, 2020, 6 (01)
  • [48] Pathologic complete response (pCR) rates after neoadjuvant pertuzumab (P) and trastuzumab (H) administered concomitantly with weekly paclitaxel (T) and 5-fluorouracil/epirubicin/cyclophosphamide (FEC) chemotherapy for clinical stage I-III HER2-positive breast cancer.
    Foldi, Julia
    Mougalian, Sarah Schellhorn
    Silber, Andrea
    Lannin, Donald R.
    Killelea, Brigid K.
    Chagpar, Anees B.
    Horowitz, Nina Ruth
    Frederick, Courtney
    Rispoli, Lawrence
    Abu-Khalaf, Maysa M.
    Sabbath, Kert D.
    Sanft, Tara Beth
    Fischbach, Neal A.
    Brandt, Debra S.
    Hofstatter, Erin Wysong
    DiGiovanna, Michael
    Pusztai, Lajos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
  • [50] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Carolin Müller
    Gilda Schmidt
    Ingolf Juhasz-Böss
    Lisa Jung
    Sarah Huwer
    Erich-Franz Solomayer
    Stephanie Juhasz-Böss
    [J]. Archives of Gynecology and Obstetrics, 2021, 304 : 1065 - 1071
12345